Criminals are targeting pharmacies and stealing weight-loss medication in a country with ... (The Brazilian market still pales in comparison to the United States, where sales totaled $30.3 billion ...

The rise of weight-loss drugs like Ozempic and Wegovy have upended ... $64.7 million — a shadow of its $6.7 billion peak. By comparison, Ozempic-maker Novo Nordisk is valued at $2.6 trillion.

As with adults, the dosage for children is based on body weight in kg. (See chart ... prescribe the drug and dosage that’s right for you. To learn more about how these drugs compare, talk ...

A groundbreaking study shows how Zepbound, a popular weight loss medication, could become a key treatment for heart failure ...

Consumer Reports warns that there are important considerations, especially for older adults, before starting these treatments ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

Nikki Laine has been taking the weight-loss drug Mounjaro for just over three weeks and has described it as "life-changing" ...

Valerie Gill started taking Contrave, a prescription weight-loss medication, 11 months ago after experiencing weight-related health issues that she found uncontrollable with methods like diet and ...

Since weight-loss drugs that target the hormone GLP-1 have surged in popularity, some additional health benefits have emerged. Beyond helping people shed pounds, they also lower the risk of heart ...

The newest generation of weight loss medications, celebrated for their remarkable effectiveness, might be hiding a concerning secret that’s making both doctors and patients take a serious pause.

Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions. This association is being called “Ozempic blindness.” Experts are not entirely clear why ...